 |
More: Advances in ADHD Management Advances in ADHD Management: Adult ADHD and Comorbidities CME Author Information and Disclosures Release Date: May 29, 2008; Valid for credit through May 29, 2009 | Physicians - maximum of 1.5 AMA PRA Category 1 Credit(s)™ for physicians | | To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details. Contents of This CME Activity- Substance Abusing Man With Bipolar Disorder and ADHDAdults with ADHD may have several concurrent psychiatric disorders. How do you decide which to manage first? When are stimulants indicated and when contraindicated?David Goodman, MD (Clinical Case, May 29, 2008)
- Comorbidity Nuts and BoltsMany adults with ADHD present because of comorbid symptoms. Uncovering ADHD in such patients requires a high index of suspicion and active interviewing. Once diagnosed, which disorder should be tackled first?Craig B.H. Surman, MD (Clinical Review, May 29, 2008)
- ADHD: Spring 2008Adult ADHD and conduct disorder; atomoxetine for alcohol use disorder; stimulants and risk for SUD; stimulant misuse in college; gender differences in adult ADHD.Paul G. Hammerness, MD (Journal Scan, May 29, 2008)
Legal DisclaimerThe material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
|
Learning Objectives Upon completion of this activity, participants will be able to: - Describe the clinical approach to successfully diagnosing and safely managing a patient with attention-deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance use disorder
- Review best practices for evaluating adults with ADHD and
psychiatric comorbidities and prioritizing treatment
- Discuss recent research on adult ADHD and conduct disorder, substance use disorders, and sex differences in comorbid symptoms
Authors and Disclosures David W. Goodman, MD
Disclosure: David W. Goodman, MD, has disclosed that he received research grants from Cephalon,
Forest Labs, McNeil, New River Pharmaceuticals, and Shire Inc.; and that he received honoraria from Forest Labs, Lilly and Company, GlaxoSmithKline, McNeil, Novartis, Shire Inc., and Wyeth. Dr. Goodman has served on the speakers' bureau of Forest Labs, GlaxoSmithKline, Lilly and Company, McNeil, Novartis, Shire Inc., and Wyeth; and served as a consultant to Forest Labs, McNeil, GlaxoSmithKline, New River Pharmaceuticals, Novartis, and Shire Labs.
Craig B.H. Surman, MD
Disclosure: Craig B.H. Surman, MD, has disclosed that he receives/d support for clinical research from, is/has been a speaker for, or is/has been on the advisory board for, or is/has received support for educational writing from the following pharmaceutical companies: Shire, Eli Lilly, McNeil, Abbott, New River Pharmaceuticals, Cephalon, Janssen, Merck, Novartis, Takeda. Other sources of research support include The Hilda
and Preston Davis Foundation, NIMH, and NIDA. Paul G. Hammerness, MD
Disclosure: Paul G. Hammerness, MD, has disclosed that he has received grants for clinical research and served on the speakers' bureau for Shire. Priscilla Scherer
Disclosure: Priscilla Scherer has disclosed no relevant financial relationships. |
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
